TRAIL is a key target in S-phase slowing-dependent apoptosis induced by interferon-β in cervical carcinoma cells
- 7 February 2005
- journal article
- Published by Springer Nature in Oncogene
- Vol. 24 (15) , 2536-2546
Abstract
Interferon (IFN)- induces S-phase slowing and apoptosis in human papilloma virus (HPV)-positive cervical carcinoma cell line ME-180. Here, we show that apoptosis is a consequence of the S-phase lengthening imposed by IFN-, demonstrating the functional correlation between S-phase alteration and apoptosis induction. In ME-180 cells, where p53 function is inhibited by HPV E6 oncoprotein, IFN- effects on cell cycle and apoptosis occur independently of p53. The apoptosis due to IFN- is mediated by the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) in a manner dependent on the S-phase deregulation. IFN- appears to increase TRAIL expression both directly at the mRNA level and indirectly by augmenting surface protein levels as a consequence of the induced S-phase cell accumulation. Moreover, the alteration of the S-phase due to IFN- promotes TRAIL-dependent apoptosis by potentiating cell sensitivity to TRAIL, possibly through induction of a proapoptotic NF-B activity and TRAIL-R2 receptor expression. Interestingly, IFN--induced TRAIL-dependent apoptotic events strongly differ in the requirement of caspase activity. These results show that IFN- may induce an apoptotic response by deregulating cell cycle. Understanding the linkage between these mechanisms appears to be of primary importance in the search for new IFN-based therapeutic strategies to circumvent cancer disease or improve clinical outcome.Keywords
This publication has 34 references indexed in Scilit:
- Emerging Applications of the Tumor Necrosis Factor Family of Ligands and Receptors in Cancer TherapyJournal of Clinical Oncology, 2003
- Interferon-α sensitizes human hepatoma cells to TRAIL-induced apoptosis through DR5 upregulation and NF-κB inactivationOncogene, 2003
- Potentiation of TRAIL-induced apoptosis in primary effusion lymphoma through azidothymidine-mediated inhibition of NF-κBBlood, 2003
- On the TRAIL to apoptosisCytokine & Growth Factor Reviews, 2002
- Human hepatocellular carcinoma cells resist to TRAIL-induced apoptosis, and the resistance is abolished by cisplatinExperimental & Molecular Medicine, 2002
- Antiviral response by natural killer cells throughTRAIL gene induction by IFN-α/βEuropean Journal of Immunology, 2001
- Induction of a TRAIL mediated suicide program by interferon alpha in primary effusion lymphomaOncogene, 2001
- Genomic Organization and Transcriptional Regulation of Human Apo2/TRAIL GeneBiochemical and Biophysical Research Communications, 2000
- Isolation and Molecular Characterization of the 5′-Upstream Region of the Human TRAIL GeneBiochemical and Biophysical Research Communications, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999